Background: Adam Brown Kelly, well known for lending his name to Paterson-Brown Kelly syndrome, is steeped in the early history of otolaryngology. To date, little light has been shone on his contributions to the specialty in that exciting period and to his home town of Glasgow.
Method: A historical review of his life and times was undertaken based on surviving accounts of his life, published work and archived memoirs.
Results: This article summarises his life and connections, with particular reference to his unique chair that has survived to this day.
Conclusion: Brown Kelly remains a pioneer of modern otolaryngology, and deserving of prominence within the medical history of Glasgow.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1017/S002221512100195X | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluating Renal Disease in Pediatric-Onset Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Disease Course, Outcomes, and Predictors of Outcome.
Arthritis Rheumatol
December 2024
University of British Columbia and BC Children's Hospital and BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
Objective: We aimed to study the disease course, outcomes, and predictors of outcome in pediatric-onset antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) affecting the kidneys.
Methods: Patients eligible for this study had a diagnosis of granulomatosis with polyangiitis (GPA), microscopic polyangiitis, or ANCA-positive pauci-immune glomerulonephritis, were 18 years or younger at diagnosis, had renal disease defined by biopsy or dialysis dependence, and had clinical data at diagnosis and at either 12 or 24 months. Ambispective data from A Registry for Children with Vasculitis/Pediatric Vasculitis Initiative Registry was used.
Feasibility, acceptability, and initial outcomes of a psychological adjustment and reintegration program for transitioned military veterans.
BMC Psychol
October 2024
Centre for Mental Health Research, National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia.
Background: Reintegration and adjustment to civilian life after military service is crucial for veterans' mental and physical health. However, there is a lack of evidence-based interventions in Australia that specifically address the psychological and cultural factors associated with improved adjustment and mental health in this group. The aim of this study was to evaluate the feasibility, acceptability, and initial outcomes of a novel group intervention program, developed to address this gap in supports and services for Australian veterans.
View Article and Find Full Text PDFComparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood-Onset Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An ARChiVe Registry Cohort Study.
Arthritis Care Res (Hoboken)
October 2024
British Columbia Children's Hospital, Vancouver, British Columbia, Canada.
Article Synopsis
- The study compares the effectiveness and toxicity of two treatments, rituximab (RTX) and cyclophosphamide (CYC), for pediatric patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).
- It analyzes data from 104 patients and finds no significant difference in remission rates or severe adverse events between the two treatment groups.
- Limitations of the study include the lack of standardized treatment protocols and the retrospective nature of the analysis.
Edetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical Trial.
JAMA
September 2024
Duke Clinical Research Institute, Duke University, Durham, North Carolina.
Article Synopsis
- - The study aimed to replicate a previous finding that EDTA-based chelation therapy reduces cardiovascular disease (CVD) events in individuals with diabetes and a history of myocardial infarction (MI).
- - Conducted at 88 sites in the US and Canada, the trial involved 959 participants who were randomly assigned to receive either chelation therapy or a placebo, with a median follow-up of 48 months.
- - Results showed no significant difference in CVD events between the chelation group (35.6% experienced a primary event) and the placebo group (35.7%), indicating that chelation may not provide the hoped-for benefits in this population.
Characteristics and Outcomes of Adults With Congenital Heart Disease in the Cardiac Intensive Care Unit.
JACC Adv
August 2024
TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Article Synopsis
- The study examines the characteristics and outcomes of adult congenital heart disease (ACHD) patients admitted to cardiac intensive care units (CICUs) in North America from 2017 to 2022, revealing limited previous knowledge in this area.
- Out of 23,299 CICU admissions, only 441 (1.9%) were for ACHD, which tended to be younger patients who had more admissions related to heart failure and medical issues compared to non-ACHD patients.
- Despite longer hospital stays for ACHD patients, their in-hospital mortality rates were similar to those of non-ACHD patients, indicating the need for more focused research on managing specific complexities related to ACHD in the CICU.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!